The involvement of catecholaminergic mechanisms in the behavioural action of vasopressin

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The effect of lysine-8-vasopressin (300 mU/kg b.w.) has been tested in a single-trial step-down passive avoidance test. Vasopressin treatment resulted in an improvement of step-down latency in normal rats, but this action disappeared when the animals were pretreated with 80 mg/kg alpha-methyl-p-tyrosine (α-MT). Vasopressin treatment decreased the hypothalamic, septal and striatal dopamine (DA) levels. Following vasopressin, the turnover of norepinephrine (NE) increased in the hypothalamus, as did these of DA in the septum and striatum. The data suggest that the cerebral catecholaminergic system might be one of the important mediators of the behavioural action of vasopressin.

Original languageEnglish
Pages (from-to)337-344
Number of pages8
JournalNeuroscience Letters
Volume5
Issue number6
DOIs
Publication statusPublished - 1977

Fingerprint

Vasopressins
Dopamine
Lypressin
alpha-Methyltyrosine
Corpus Striatum
Hypothalamus
Norepinephrine

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The involvement of catecholaminergic mechanisms in the behavioural action of vasopressin. / Kovács, G.; Vécsei, L.; Szabó, Gyula; Telegdy, G.

In: Neuroscience Letters, Vol. 5, No. 6, 1977, p. 337-344.

Research output: Contribution to journalArticle

@article{cf1703f1902d4c9dae86d2b7530c7cb6,
title = "The involvement of catecholaminergic mechanisms in the behavioural action of vasopressin",
abstract = "The effect of lysine-8-vasopressin (300 mU/kg b.w.) has been tested in a single-trial step-down passive avoidance test. Vasopressin treatment resulted in an improvement of step-down latency in normal rats, but this action disappeared when the animals were pretreated with 80 mg/kg alpha-methyl-p-tyrosine (α-MT). Vasopressin treatment decreased the hypothalamic, septal and striatal dopamine (DA) levels. Following vasopressin, the turnover of norepinephrine (NE) increased in the hypothalamus, as did these of DA in the septum and striatum. The data suggest that the cerebral catecholaminergic system might be one of the important mediators of the behavioural action of vasopressin.",
author = "G. Kov{\'a}cs and L. V{\'e}csei and Gyula Szab{\'o} and G. Telegdy",
year = "1977",
doi = "10.1016/0304-3940(77)90110-0",
language = "English",
volume = "5",
pages = "337--344",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "6",

}

TY - JOUR

T1 - The involvement of catecholaminergic mechanisms in the behavioural action of vasopressin

AU - Kovács, G.

AU - Vécsei, L.

AU - Szabó, Gyula

AU - Telegdy, G.

PY - 1977

Y1 - 1977

N2 - The effect of lysine-8-vasopressin (300 mU/kg b.w.) has been tested in a single-trial step-down passive avoidance test. Vasopressin treatment resulted in an improvement of step-down latency in normal rats, but this action disappeared when the animals were pretreated with 80 mg/kg alpha-methyl-p-tyrosine (α-MT). Vasopressin treatment decreased the hypothalamic, septal and striatal dopamine (DA) levels. Following vasopressin, the turnover of norepinephrine (NE) increased in the hypothalamus, as did these of DA in the septum and striatum. The data suggest that the cerebral catecholaminergic system might be one of the important mediators of the behavioural action of vasopressin.

AB - The effect of lysine-8-vasopressin (300 mU/kg b.w.) has been tested in a single-trial step-down passive avoidance test. Vasopressin treatment resulted in an improvement of step-down latency in normal rats, but this action disappeared when the animals were pretreated with 80 mg/kg alpha-methyl-p-tyrosine (α-MT). Vasopressin treatment decreased the hypothalamic, septal and striatal dopamine (DA) levels. Following vasopressin, the turnover of norepinephrine (NE) increased in the hypothalamus, as did these of DA in the septum and striatum. The data suggest that the cerebral catecholaminergic system might be one of the important mediators of the behavioural action of vasopressin.

UR - http://www.scopus.com/inward/record.url?scp=0017707795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017707795&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(77)90110-0

DO - 10.1016/0304-3940(77)90110-0

M3 - Article

VL - 5

SP - 337

EP - 344

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 6

ER -